glp 1 and breast cancer survivor 💉 What should oncology nurses know about GLP-1 therapy in survivorship? GLP-1 receptor agonists are gaining attention beyond diabetes management, with emerging research exploring their potential role in cancer survivorship Sharing some research on GLP-1

The ruling does not necessarily prohibit all tirzepatide compounding, but it does constrain the circumstances under which it is permitted

As competitors rush to create new weight loss drugs, other companies are compounding existing medications, including Hims and Hers, a healthcare company known for its telehealth services, and digital health startup Noom

Youre an individual, youve got a different lifestyle, different tolerance for pain and hunger

Glutathione supplements are gaining popularity in wellness

02.20.25 Large analysis of diabetic patients found increase in NAION An analysis of 37.1 million adults with type 2 diabetes across 14 databases found further evidence of an association between semaglutide and NAION. 02.03.25 MDL numbers expanded ahead of February The number of pending actions in the GLP-1 MDL increased to 1,443

Its like having a mini universe inside you